On the heels of disappointing phase 2 results, Regeneron Pharmaceuticals, Inc. says it will discontinue development of their aflibercept/nesvacumab combination therapy for diabetic macular edema (DME) and wet AMD. Source: AAO
RxSight Inc. announced the approval of a first-of-its-kind system that can correct minor residual refractive errors by making postoperative adjustments to the IOL power. Source: AAO
This study finds that aqueous humor from retinoblastoma eyes contains tumor-derived DNA that can be analyzed as an alternative to tissue biopsy. Source: AAO
The Academy is seeking help from cataract surgeons to assist with a collaborative project for developing a patient-reported outcome (PRO) instrument. Source: AAO
The FDA has granted orphan status to IVMED-80, a daily eye drop for keratoconus. Source: AAO
These uveitis papers published in 2016 were selected by members of the American Uveitis Society for their outstanding teaching value for residents. Source: AAO
Age has a way of provoking unwanted changes. For many of us, our vision is one of the first indicators that we are getting older. The bad news is that our biology naturally changes with time. The good news is that there are strategies that can be implemented to reduce the effects of aging. Here, […]
Diabetes is a concerning health condition that affects nearly half of the adults in our country. When diabetes is a known health problem, proper eye care needs to take a place of priority. The fluctuations in blood sugar have a direct effect on overall eye health, affecting the integrity of ocular structures such as the […]
Due to a labeling error, Fresenius Kabi USA is voluntarily recalling lot 6400048 of Midazolam Injection, USP, 2 mg/2 mL. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
